Susan F. Leitman

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

Steven A. Rosenberg, Michael T. Lotze, Linda Muul et al. · New England Journal of Medicine · 1987 · 2.8K citations

Pharmacy, Immunology, Oncology +14

Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

Steven A. Rosenberg, Michael T. Lotze, Linda Muul et al. · New England Journal of Medicine · 1985 · 2.6K citations

Medicine, Immunology, Oncology +15

Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens

Mark E. Dudley, James Chih‐Hsin Yang, Richard M. Sherry et al. · Journal of Clinical Oncology · 2008 · 1.3K citations · Full text

Medicine, Immunology, Oncology +17

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

Richard Childs, Allen Chernoff, Nathalie Contentin et al. · New England Journal of Medicine · 2000 · 1K citations · Full text

Medicine, Hematology, Oncology +15

Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

Claudio Anasetti, Brent R. Logan, Stephanie J. Lee et al. · New England Journal of Medicine · 2012 · 905 citations · Full text

Medicine, Hematology, Immunology +15